13F-HR/A filed by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC filed this 13F-HR/A for the quarter ended 2019-03-31, filed 2019-05-16, with 105 holding rows worth $3,544,255,000.
- Accession
- 0001012975-19-000380
- Filer
- CIK 1224962
- Filed
- 2019-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2019
A holdings report, amendment of type restatement, 105 entries on the cover page, a total value of $3,544,255,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,544,255,000 with VALUE read as thousands by filing date, 13F file number 028-10438. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 3,758,662 | $331,138,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 21,639,486 | $294,297,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 5,525,726 | $292,476,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 3,869,491 | $212,860,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 6,540,957 | $135,790,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,113,328 | $131,039,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 12,235,811 | $116,362,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,007,746 | $103,513,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 4,228,900 | $103,101,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 1,271,054 | $101,748,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 10,789,054 | $97,209,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 1,164,382 | $85,349,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 3,054,707 | $69,128,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 1,145,726 | $65,662,000 | thousands by filing date | |
| MERIT MED SYS INC COM | 589889104 | Stock | 1,053,098 | $65,113,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 1,400,171 | $62,770,000 | thousands by filing date | |
| ATHENEX INC | 04685N103 | COM | 5,096,022 | $62,426,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 2,587,953 | $58,901,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 4,212,821 | $55,946,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 1,704,330 | $54,896,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 988,511 | $51,393,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 2,171,918 | $50,866,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 1,543,790 | $44,630,000 | thousands by filing date | |
| VBI VACCINES INC | 91822J103 | COM NEW | 23,951,556 | $42,633,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 2,875,000 | $41,774,000 | thousands by filing date | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 3,410,412 | $38,537,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC | 3422E1055 | COM | 3,927,222 | $36,130,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 4,805,650 | $35,514,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 13,165,746 | $34,757,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,173,923 | $34,120,000 | thousands by filing date | |
| NEPTUNE WELLNESS SOLUTIONS I | 64079L105 | COM | 8,891,452 | $28,363,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 3,085,458 | $27,862,000 | thousands by filing date | |
| DOVA PHARMACEUTICALS INC | 25985T102 | COM | 3,125,851 | $27,788,000 | thousands by filing date | |
| TELADOC HEALTH INC | 87918A105 | COM | 495,000 | $27,522,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 2,204,641 | $26,610,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 416,949 | $26,063,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS INC | 4366E1029 | COM | 2,071,297 | $26,036,000 | thousands by filing date | |
| ADMA BIOLOGICS INC | 000899104 | COM | 6,521,102 | $24,715,000 | thousands by filing date | |
| VAPOTHERM INC | 922107107 | COM | 1,246,315 | $24,490,000 | thousands by filing date | |
| KODIAK SCIENCES INC | 50015M109 | COM | 3,135,199 | $20,472,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 289,857 | $18,070,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 4,661,824 | $17,482,000 | thousands by filing date | |
| AXONICS INC | 05465P101 | COM | 685,756 | $16,424,000 | thousands by filing date | |
| EIDOS THERAPEUTICS INC. | 28249H104 | Common Stock | 686,992 | $16,109,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 200,000 | $14,992,000 | thousands by filing date | |
| BAUSCH HEALTH COS INC COM | 071734107 | Stock | 600,000 | $14,820,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 614,242 | $14,766,000 | thousands by filing date | |
| AQUESTIVE THERAPEUTICS INC | 3843E1047 | COM | 2,113,400 | $14,603,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 1,703,440 | $13,951,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 231,820 | $13,828,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 502,970 | $13,786,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 4,400,440 | $13,509,000 | thousands by filing date | |
| MARKER THERAPEUTICS INC | 57055L107 | COM | 2,000,000 | $13,200,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 8,426,750 | $12,724,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 3,210,542 | $12,521,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 1,974,133 | $11,470,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 722,523 | $10,021,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 511,731 | $9,579,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 521,800 | $9,329,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 35,000 | $9,310,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 1,128,524 | $8,700,000 | thousands by filing date | |
| UROVANT SCIENCES | G9381B108 | COMMON STOCK | 865,359 | $8,697,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 573,890 | $8,529,000 | thousands by filing date | |
| ANI PHARMACEUTICALS INC | 00182CAA1 | NOTE 3.00012/0 | 7,500,000 | $8,239,000 | thousands by filing date | principal |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 458,173 | $8,036,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 867,852 | $6,587,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 330,738 | $6,069,000 | thousands by filing date | |
| SHOCKWAVE MED INC | 82489T104 | COM | 150,000 | $5,021,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U107 | COM | 2,666,190 | $4,559,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 435,000 | $4,433,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 40,000 | $3,890,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 50,000 | $3,468,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 70,000 | $2,251,000 | thousands by filing date | |
| Veru Inc | 92536C103 | Common Stock | 1,425,000 | $2,081,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 139,890 | $1,955,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y115 | *W EXP 12/24/201 | 659,636 | $1,906,000 | thousands by filing date | |
| ACASTI PHARMA INC | 00430K402 | CL A NEW | 1,779,882 | $1,815,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 1,719,111 | $1,787,000 | thousands by filing date | |
| VOCERA COMMUNICATIONS INC | 92857F107 | COMMON STOCK | 50,000 | $1,582,000 | thousands by filing date | |
| ARTIVION INC | 228903100 | COM | 50,000 | $1,459,000 | thousands by filing date | |
| ABEONA THERAPEUTICS INC | 00289Y107 | COM | 180,797 | $1,331,000 | thousands by filing date | |
| AVEDRO INC | 05355N109 | COM | 100,000 | $1,227,000 | thousands by filing date | |
| Allena Pharmaceuticals, Inc. | 018119107 | COM | 132,300 | $929,000 | thousands by filing date | |
| FIAT CHRYSLER AUTOMOBILES N | N31739102 | SHS | 62,000 | $920,000 | thousands by filing date | |
| FERRARI N V | N3167Y103 | COM | 6,200 | $830,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 12,844 | $816,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 31,521 | $789,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 53,879 | $767,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 200,000 | $660,000 | thousands by filing date | put |
| BIOGEN INC COM | 09062X103 | Stock | 400,000 | $620,000 | thousands by filing date | call |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 46,030 | $612,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 9,306 | $506,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 28,090 | $492,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 100,000 | $421,000 | thousands by filing date | call |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 14,897 | $400,000 | thousands by filing date | |
| BIOTELEMETRY INC | 090672106 | COM | 6,369 | $399,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 15,232 | $344,000 | thousands by filing date | |
| OUTLOOK THERAPEUTICS INC | 69012T115 | *W EXP 02/18/202 | 420,875 | $159,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 200,000 | $140,000 | thousands by filing date | call |
| IMMUNOMEDICS INC | 452907108 | COM | 200,000 | $125,000 | thousands by filing date | call |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 200,000 | $125,000 | thousands by filing date | call |
| SOLID BIOSCIENCES INC | 3422E1055 | COM | 10,000 | $29,000 | thousands by filing date | call |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 200,000 | $25,000 | thousands by filing date | put |
| ONCOSEC MED INC | 68234L207 | COM NEW | 30,000 | $17,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 600,000 | $15,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-19-000378 | superseded | 2019-05-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001012975-19-000380 | this filing | 2019-05-16 | acceptance time not in the bulk data set |